2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2009
November 23, 2009
Human Genome Sciences and Aegera Therapeutics Announce Initiation of Clinical Trial of Lead IAP Inhibitor HGS 1029 in Advanced Lymphoid Tumors
November 19, 2009
Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the treatment of Acute Myeloid Leukemia (AML)
September 23, 2009
Aegera Therapeutics Closes $7 Million Financing
September 23, 2009
Humane Genone Sciences and Aegera Therapeutics Announce Initiation of Clinical Trial of Lead IAP Inhibitor HGS 1029 in Advances Lymphoid Tumors
May 06, 2009
Aegera initiates Phase 2 Clinical Trial of AEG33773
January 08, 2009
Aegera Therapeutics Initiates A Randomized Phase 2 Combination Study of AEG35156 for 1st Line Treatment of Non-Small Cell Lung Cancer
About Aegera
|
Pipeline
|
Clinical Trials
|
Partnerships
|
Media
|
Careers
|
Contact Us
|
Français
© 2010 Aegera Therapeutics Inc. All rights reserved. Developed by
Grafika Designs
.
